Register Login

Revance Therapeutics (RVNC)

  • From: Oct. 10, 2022, 10:00
  • To: Oct. 10, 2022, 12:00 UTC

Revance to Present Clinical Data on the Efficacy and Safety Profile of DAXXIFY™ (DaxibotulinumtoxinA-lanm) for Injection at the 2022 American Society for Dermatologic Surgery (ASDS) Annual Meeting

Full text

Event calendar menu

Dashboard

Upcoming event

Running event

Completed event

All event